Evolving Landscape of Open-Angle Glaucoma Pipeline Therapies in 2024
September 25, 2024 04:12 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Open-Angle Glaucoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive analytical report has been...
Nicox et Glaukos signent un accord exclusif de recherche incluant une option de licence mondiale pour NCX 1728
September 23, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox et Glaukos signent un accord exclusif de recherche incluant une option de licence mondiale pour NCX 1728 L’option permettra à Glaukos de conclure des accords exclusifs de...
Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement
September 23, 2024 01:30 ET
|
NICOX SA
Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement Option entitles Glaukos to exclusive global license agreements on pre-agreed terms including...
Nicox annonce l’approbation de ZERVIATE en Chine
September 18, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox annonce l’approbation de ZERVIATE en Chine Ocumension Therapeutics, partenaire licencié de Nicox, a reçu l'approbation de la demande d'autorisation de mise sur le marché en...
Nicox Announces Approval of ZERVIATE in China
September 18, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will...
Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration
September 04, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration Christine Placet est Directrice Financière chez Theranexus, et a été...
Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board
September 04, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Christine Placet is CFO of Theranexus, and was formerly CEO of Horama and TrophosMichele...
Nicox : Recrutement du dernier patient aux Etats- Unis dans l’étude clinique de phase 3 Denali sur NCX 470
July 25, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox : Recrutement du dernier patient aux Etats-Unis dans l’étude clinique de phase 3 Denali sur NCX 470 Le recrutement se poursuit en Chine, avec les premiers résultats...
Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470
July 25, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470 Recruitment continues in China, on track for topline results in H2 2025 NCX 470 demonstrated...
Nicox announces attendance at upcoming conferences
July 19, 2024 01:30 ET
|
NICOX SA
Press Release Nicox announces attendance at upcoming conferencesJuly 19th, 2024 – release at 7:30 am CETSophia Antipolis, FranceNicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international...